tiprankstipranks
Trending News
More News >
Avisa Diagnostics (FOGCF)
OTHER OTC:FOGCF
US Market

Avisa Diagnostics (FOGCF) Price & Analysis

Compare
14 Followers

FOGCF Stock Chart & Stats

$0.02
$0.00(0.00%)
At close: 4:00 PM EST
$0.02
$0.00(0.00%)

FOGCF FAQ

What was Avisa Diagnostics’s price range in the past 12 months?
Avisa Diagnostics lowest stock price was $0.03 and its highest was $0.03 in the past 12 months.
    What is Avisa Diagnostics’s market cap?
    Avisa Diagnostics’s market cap is $1.92M.
      When is Avisa Diagnostics’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Avisa Diagnostics’s earnings last quarter?
      Currently, no data Available
      Is Avisa Diagnostics overvalued?
      According to Wall Street analysts Avisa Diagnostics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Avisa Diagnostics pay dividends?
        Avisa Diagnostics does not currently pay dividends.
        What is Avisa Diagnostics’s EPS estimate?
        Avisa Diagnostics’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Avisa Diagnostics have?
        Avisa Diagnostics has 43,241,310 shares outstanding.
          What happened to Avisa Diagnostics’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Avisa Diagnostics?
          Currently, no hedge funds are holding shares in FOGCF
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Avisa Diagnostics

            Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and communityacquired pneumonia. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is based in Santa Fe, New Mexico.
            Similar Stocks
            Company
            Price & Change
            Follow
            AXIM Biotechnologies
            Advaxis
            BioNano Genomics
            Guided Therapeutics
            Inmune Bio
            Idexx Laboratories
            Popular Stocks